Treatment Of Myasthenia Gravis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GTBP | D | GT Biopharma, Inc. | -5.64 | |
IMVT | F | Immunovant, Inc. | 1.41 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Myasthenia Gravis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 2.66 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 1.46 | |
BBC | F | Virtus LifeSci Biotech Clinical Trials ETF | 0.87 | |
XBI | D | SPDR S&P Biotech ETF | 0.62 | |
NSCS | A | Nuveen Small Cap Select ETF | 0.43 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 15 | GTBP | GT Biopharma GAAP EPS of -$1.53 |
Related Industries:
Biotechnology
- Treatment Of Myasthenia Gravis
Treatment of myasthenia gravis typically involves medications, such as cholinesterase inhibitors, immunosuppressants, and corticosteroids, as well as other therapies, such as plasmapheresis and thymectomy. The goal of treatment is to reduce the severity of symptoms and improve the patient's quality of life.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles